PepGen

Stop sign
Biotech

PepGen pauses UK arm of DMD trial that's already on hold in US

The trial of PepGen’s PGN-EDO51 exon-skipping Duchenne muscular dystrophy therapy was placed on hold by the FDA in December.
James Waldron Mar 4, 2025 10:25am
FDA stop sign

FDA hits pause on another of PepGen's muscular dystrophy trials

Dec 16, 2024 9:45am
Paragliding over the cliffs Fort Funston San Francisco

BioMarin builds exec team with biotech vets—Chutes & Ladders

Aug 23, 2024 8:30am
Alps parachute rainbow mountains

J&J, Bayer, Santa Ana, Regenxbio and more—Chutes & Ladders

Jun 14, 2024 8:30am
steps race jump stairs climb

PepGen gains a little pep in its step as FDA clears trial hold

Oct 12, 2023 7:00am
Letter opening FDA clinical hold

Awaiting FDA letter, PepGen oligonucleotide no closer to clinic

Jun 14, 2023 9:05am